liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
AstraZeneca, England.
AstraZeneca, England.
Maastricht Univ Med Ctr, Netherlands.
Maastricht Univ Med Ctr, Netherlands.
Show others and affiliations
2023 (English)In: Nature Metabolism, E-ISSN 2522-5812, Vol. 5, p. 2086-2093Article in journal (Refereed) Published
Abstract [en]

Cotadutide is a dual glucagon-like peptide 1 and glucagon receptor agonist under development for the treatment of non-alcoholic steatohepatitis and type 2 diabetes mellitus (T2DM) and chronic kidney disease. Non-alcoholic steatohepatitis is a complex disease with no approved pharmacotherapies, arising from an underlying state of systemic metabolic dysfunction in association with T2DM and obesity. Cotadutide has been shown to improve glycaemic control, body weight, lipids, liver fat, inflammation and fibrosis. We conducted a two-part, randomized phase 2a trial in men and women with overweight or obesity diagnosed with T2DM to evaluate the efficacy and safety of cotadutide compared with placebo and liraglutide. The primary endpoints were change from baseline to day 28 of treatment in postprandial hepatic glycogen (part A) and to day 35 of treatment in fasting hepatic glycogen (part B) with cotadutide versus placebo. Secondary endpoints in part B were changes in fasting hepatic glycogen with cotadutide versus the mono glucagon-like peptide 1 receptor agonist, liraglutide, and change in hepatic fat fraction. The trial met its primary endpoint. We showed that cotadutide promotes greater reductions in liver glycogen and fat compared with placebo and liraglutide. Safety and tolerability findings with cotadutide were comparable to those of previous reports. Thus, this work provides evidence of additional benefits of cotadutide that could be attributed to glucagon receptor engagement. Our results suggest that cotadutide acts on the glucagon receptor in the human liver to promote glycogenolysis and improve the metabolic health of the liver. ClinicalTrials.gov registration: NCT03555994. In a two-part randomized phase 2a trial in men and women with overweight or obesity and type 2 diabetes mellitus, cotadutide promoted greater reductions in liver glycogen and fat than placebo and liraglutide.

Place, publisher, year, edition, pages
NATURE PORTFOLIO , 2023. Vol. 5, p. 2086-2093
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-200002DOI: 10.1038/s42255-023-00938-0ISI: 001117026600001PubMedID: 38066113OAI: oai:DiVA.org:liu-200002DiVA, id: diva2:1826207
Note

Funding Agencies|AstraZeneca

Available from: 2024-01-11 Created: 2024-01-11 Last updated: 2024-05-03

Open Access in DiVA

fulltext(4815 kB)229 downloads
File information
File name FULLTEXT01.pdfFile size 4815 kBChecksum SHA-512
574b62aedbb480d68902d82d711fe6e3b2068edc80428c1334c28afc6d4777d35746085778c36b0dd4111385034f88c8f9bda204afae2974fe9055220a623a37
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Sjöberg, Folke

Search in DiVA

By author/editor
Sjöberg, Folke
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health SciencesDepartment of Hand and Plastic Surgery
In the same journal
Nature Metabolism
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 229 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 233 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf